If (and that is a big if) phase 3 is like phase 2...HOMERUN. Both fibroids and endometriosis is a huge womens health issue. That is why so many hysterectomies are done (fibroids). Endometriosis (a smaller market) is much more difficult to treat so any new option that works will be very successful. I can't give you a number for the overall market other than it would be huge. Dewophile (also an MD in this particualr field) would likely be better at estimating the actual market.
News 
Market Data 
Discover 
AI
